Mga Batayang Estadistika
| LEI | 549300Z86PUW4ENZCD61 |
| CIK | 1131096 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Athena Technology Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one shar
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| February 21, 2019 |
ATHN / athenahealth, Inc. 15-12B 15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-33689 athenahealth, Inc. (Exact name of registrant as specified i |
|
| February 12, 2019 |
ATHN / athenahealth, Inc. / Wellington Management Group LLP - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5 )* athenahealth, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 04685W103 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to |
|
| February 12, 2019 |
ATHN / athenahealth, Inc. / Elliott Associates, L.P. - ATHENAHEALTH, INC. Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 3)* Under the Securities Exchange Act of 1934 athenahealth, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 04685W103 (CUSIP Number) Elliott Associates, L.P. c/o Elliott Management Corporation 40 West 57th Street New York, NY 10019 with a copy to: Eleazer Klein, Esq. Marc Wein |
|
| February 11, 2019 |
ATHN / athenahealth, Inc. S-8 POS S-8 POS As filed with the Securities and Exchange Commission on February 11, 2019 Registration Nos. |
|
| February 11, 2019 |
ATHN / athenahealth, Inc. S-8 POS S-8 POS As filed with the Securities and Exchange Commission on February 11, 2019 Registration Nos. |
|
| February 11, 2019 |
ATHN / athenahealth, Inc. S-8 POS S-8 POS As filed with the Securities and Exchange Commission on February 11, 2019 Registration Nos. |
|
| February 11, 2019 |
SEVENTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION ATHENAHEALTH, INC. Exhibit 3.1 SEVENTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ATHENAHEALTH, INC. **** FIRST: The name of the Corporation is athenahealth, Inc. SECOND: The address of the Corporation’s registered office in the State of Delaware is COGENCY GLOBAL INC., 850 New Burton Road, Suite 201, County of Kent, Dover, Delaware 19904. The name of its registered agent at such address is COGENCY GLOBAL |
|
| February 11, 2019 |
BY-LAWS OF ATHENAHEALTH, INC. Article I OFFICES Exhibit 3.2 BY-LAWS OF ATHENAHEALTH, INC. Article I OFFICES Section 1.01 Offices. The registered office of athenahhealth, Inc. (the “Corporation”) shall be COGENCY GLOBAL INC., 850 New Burton Road, Suite 201, Dover, County of Kent, Delaware 19904. The name of its registered agent at such address is COGENCY GLOBAL INC. The Corporation may have other offices, both within and without the State of Del |
|
| February 11, 2019 |
Exhibit 99.1 Veritas Capital Completes Acquisition of athenahealth Evergreen Coast Capital to be Minority Investor in Combination of athenahealth and Veritas-Backed Virence Bob Segert to Serve as Chairman and CEO WATERTOWN, Mass. and NEW YORK - February 11, 2019 - athenahealth, Inc., a leading provider of network-enabled services for hospital and ambulatory customers nationwide, announced today th |
|
| February 11, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 11, 2019 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission Fi |
|
| February 11, 2019 |
ATHN / athenahealth, Inc. S-8 POS S-8 POS As filed with the Securities and Exchange Commission on February 11, 2019 Registration Nos. |
|
| February 11, 2019 |
ATHN / athenahealth, Inc. S-8 POS S-8 POS As filed with the Securities and Exchange Commission on February 11, 2019 Registration Nos. |
|
| February 11, 2019 |
ATHN / athenahealth, Inc. / VANGUARD GROUP INC Passive Investment athenahealthinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6 )* Name of issuer: athenahealth Inc Title of Class of Securities: Common Stock CUSIP Number: 04685W103 Date of Event Which Requires Filing of this Statement: December 31, 2018 Check the appropriate box to |
|
| February 11, 2019 |
ATHN / athenahealth, Inc. S-8 POS S-8 POS As filed with the Securities and Exchange Commission on February 11, 2019 Registration Nos. |
|
| February 7, 2019 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 7, 2019 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission Fil |
|
| January 31, 2019 |
ATHN / athenahealth, Inc. / VANGUARD SPECIALIZED FUNDS Passive Investment athenahealthinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.:2 )* Name of issuer: athenahealth Inc Title of Class of Securities: Common Stock CUSIP Number: 04685W103 Date of Event Which Requires Filing of this Statement: December 31, 2018 Check the appropriate box to d |
|
| January 28, 2019 |
ATHN / athenahealth, Inc. DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Pro |
|
| January 28, 2019 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 28, 2019 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission |
|
| December 27, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2018 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission Fi |
|
| December 21, 2018 |
ATHN / athenahealth, Inc. DEFM14A DEFM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 4, 2018 |
ATHN / athenahealth, Inc. PREM14A PREM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 4, 2018 |
8-K 1 athnform8-kxitem502transac.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2018 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other juri |
|
| December 4, 2018 |
Form of Transaction Bonus Agreement. EX-10.1 2 exhibit101-transactionbonu.htm EXHIBIT 10.1 Exhibit 10.1 Transaction Bonus Agreement This Transaction Bonus Agreement (this “Agreement”) is entered into and effective as of DATE (the “Effective Date”), by and between athenahealth, Inc. (together with its affiliates, the “Company”), and NAME (“you”). In consideration of the mutual promises and consideration set forth herein, the parties a |
|
| November 23, 2018 |
ATHN / athenahealth, Inc. DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Pro |
|
| November 16, 2018 |
ATHN / athenahealth, Inc. DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Pro |
|
| November 14, 2018 |
ATHN / athenahealth, Inc. DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Pro |
|
| November 13, 2018 |
ATHN / athenahealth, Inc. DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Pro |
|
| November 13, 2018 |
ATHN / athenahealth, Inc. DEFA14A DEFA14A 1 d647967ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| November 13, 2018 |
ATHN / athenahealth, Inc. DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Pro |
|
| November 13, 2018 |
EX-2.1 Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER among ATHENAHEALTH, INC., MAY HOLDING CORP. and MAY MERGER SUB INC. Dated as of November 11, 2018 TABLE OF CONTENTS Page ARTICLE I THE MERGER; CLOSING; EFFECTIVE TIME 1 1.1 The Merger 1 1.2 Closing 2 1.3 Effective Time 3 1.4 Closing Deliverables: 3 ARTICLE II ORGANIZATIONAL DOCUMENTS OF THE SURVIVING CORPORATION 3 2.1 The Certific |
|
| November 13, 2018 |
EX-99.1 Exhibit 99.1 athenahealth Enters Definitive Agreement to be Acquired by Veritas Capital For $135 Per Share in Cash Evergreen Coast Capital to be Minority Investor in Combination of athenahealth and Veritas-Backed Virence WATERTOWN, Mass., SEATTLE, Wash. and NEW YORK – November 12, 2018 – athenahealth, Inc. (NASDAQ: ATHN), a leading provider of network-enabled services for hospital and ambu |
|
| November 13, 2018 |
8-K Privileged & Confidential UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 13, 2018 |
EX-2.1 Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER among ATHENAHEALTH, INC., MAY HOLDING CORP. and MAY MERGER SUB INC. Dated as of November 11, 2018 TABLE OF CONTENTS Page ARTICLE I THE MERGER; CLOSING; EFFECTIVE TIME 1 1.1 The Merger 1 1.2 Closing 2 1.3 Effective Time 3 1.4 Closing Deliverables: 3 ARTICLE II ORGANIZATIONAL DOCUMENTS OF THE SURVIVING CORPORATION 3 2.1 The Certific |
|
| November 13, 2018 |
8-K Privileged & Confidential UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 13, 2018 |
Joint Press Release dated November 12, 2018. EX-99.1 3 d644492dex991.htm EX-99.1 Exhibit 99.1 athenahealth Enters Definitive Agreement to be Acquired by Veritas Capital For $135 Per Share in Cash Evergreen Coast Capital to be Minority Investor in Combination of athenahealth and Veritas-Backed Virence WATERTOWN, Mass., SEATTLE, Wash. and NEW YORK – November 12, 2018 – athenahealth, Inc. (NASDAQ: ATHN), a leading provider of network-enabled se |
|
| November 13, 2018 |
ATHN / athenahealth, Inc. / Elliott Associates, L.P. - ATHENAHEALTH, INC. Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 2)* Under the Securities Exchange Act of 1934 athenahealth, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 04685W103 (CUSIP Number) Elliott Associates, L.P. c/o Elliott Management Corporation 40 West 57th Street New York, NY 10019 with a copy to: Eleazer Klein, Esq. Marc Wein |
|
| November 9, 2018 |
Exhibit 99.2 Third Quarter Fiscal Year 2018 Prepared Remarks and Supplemental Metrics November 9, 2018 Jeffrey R. Immelt, Executive Chairman of the Board of Directors Marc A. Levine, Chief Financial Officer About These Remarks The following commentary is provided by management in conjunction with the third quarter fiscal year 2018 earnings press release issued by athenahealth, Inc. (“athenahealth” |
|
| November 9, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2018 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission Fil |
|
| November 9, 2018 |
Exhibit 99.1 athenahealth Reports Third Quarter Fiscal Year 2018 Results Company Reaffirms Fiscal Year 2018 Financial Outlook WATERTOWN, MA – November 9, 2018 – athenahealth, Inc. (NASDAQ: ATHN) (“athenahealth” or “we”), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, today announced financial and operational results for the third quarter of fiscal ye |
|
| November 9, 2018 |
ATHN / athenahealth, Inc. 10-Q (Quarterly Report) 10-Q 1 athn-20180930x10q.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition pe |
|
| November 9, 2018 |
[Reminder of the page intentionally left blank.] Exhibit 10.1 Execution Version September 5, 2018 Mr. Jonathan Bush 15 Hubbard Park Rd Cambridge, MA 02138 Dear Jonathan, This letter agreement (the “Agreement”) sets forth the severance payments and benefits to be provided to you in connection with your separation of employment from athenahealth, Inc. and its affiliates (together, the “Company”) on June 6, 2018 (the “Separation Date”). You acknowl |
|
| September 5, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 29, 2018 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission File |
|
| August 13, 2018 |
ATHN / athenahealth, Inc. S-8 POS As filed with the Securities and Exchange Commission on August 13, 2018 Registration No. |
|
| August 13, 2018 |
ATHN / athenahealth, Inc. 10-Q/A (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A (Amendment No. 1) (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0 |
|
| August 13, 2018 |
ATHENAHEALTH, INC. 2007 EMPLOYEE STOCK PURCHASE PLAN AS AMENDED & RESTATED EX-10.1 2 exhibit101toform10-qa.htm EXHIBIT 10.1 EXHIBIT 10.1 ATHENAHEALTH, INC. 2007 EMPLOYEE STOCK PURCHASE PLAN AS AMENDED & RESTATED The purpose of the 2007 Employee Stock Purchase Plan (“the Plan”) is to provide eligible employees of athenahealth, Inc. (the “Company”) and each Designated Subsidiary (as defined in Section 11) with opportunities to purchase shares of the Company’s common stock, |
|
| July 31, 2018 |
As filed with the Securities and Exchange Commission on July 31, 2018 Registration No. |
|
| July 30, 2018 |
Exhibit 99.2 Second Quarter Fiscal Year 2018 Prepared Remarks and Supplemental Metrics July 30, 2018 Jeffrey R. Immelt, Executive Chairman of the Board of Directors Marc A. Levine, Chief Financial Officer About These Remarks The following commentary is provided by management in conjunction with the second quarter fiscal year 2018 earnings press release issued by athenahealth, Inc. (“athenahealth” |
|
| July 30, 2018 |
Exhibit 99.1 athenahealth Reports Second Quarter Fiscal Year 2018 Results Company Achieves Strong Revenue and Earnings Growth; Updates Fiscal Year 2018 Financial Outlook WATERTOWN, MA – July 30, 2018 – athenahealth, Inc. (NASDAQ: ATHN) (“athenahealth” or “we”), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, today announced financial and operational r |
|
| July 30, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 athnq22018form8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2018 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of in |
|
| July 30, 2018 |
ATHENAHEALTH, INC. 2007 EMPLOYEE STOCK PURCHASE PLAN AS AMENDED & RESTATED Exhibit 10.1 ATHENAHEALTH, INC. 2007 EMPLOYEE STOCK PURCHASE PLAN AS AMENDED & RESTATED The purpose of the 2007 Employee Stock Purchase Plan (“the Plan”) is to provide eligible employees of athenahealth, Inc. (the “Company”) and each Designated Subsidiary (as defined in Section 11) with opportunities to purchase shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”). |
|
| July 30, 2018 |
Exhibit 10.2 Retention Bonus Agreement This Retention Bonus Agreement (this “Agreement”) is entered into and effective as of DATE (the “Effective Date”), by and between athenahealth, Inc. (together with its affiliates, the “Company”), and NAME (“you”). In consideration of the mutual promises and consideration set forth herein, the parties agree as follows: 1.At-Will Employment. This Agreement is n |
|
| July 30, 2018 |
ATHN / athenahealth, Inc. 10-Q (Quarterly Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001 |
|
| June 12, 2018 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 6, 2018 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission File Num |
|
| June 6, 2018 |
EX-99.1 2 finalathnrelease6-6x18.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE athenahealth Initiates Process to Explore Strategic Alternatives, Including Search for New Chief Executive Officer Jonathan Bush Steps Down as President, CEO and Director of athenahealth; Jeff Immelt Appointed Executive Chairman; CFO Marc Levine to Assume Additional Operational Responsibilities; Board Member Dr. A |
|
| June 6, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2018 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| May 18, 2018 |
ATHN / athenahealth, Inc. / HENDERSON GROUP PLC Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 athenahealth, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 04685W103 (CUSIP Number) Janus Henderson Group plc c/o Stephen Andersen, VP Compliance 151 Detroit St Denver, CO 80206 303-333-3863 (Name, Address and Telephone Number of Person Authorized to R |
|
| May 7, 2018 |
ATHN / athenahealth, Inc. / Elliott Associates, L.P. - ATHENAHEALTH, INC. Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 1)* Under the Securities Exchange Act of 1934 athenahealth, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 04685W103 (CUSIP Number) Elliott Associates, L.P. c/o Elliott Management Corporation 40 West 57th Street New York, NY 10019 with a copy to: Eleazer Klein, Esq. Marc Wein |
|
| April 26, 2018 |
ATHN / athenahealth, Inc. DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| April 26, 2018 |
ATHN / athenahealth, Inc. DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitte |
|
| April 26, 2018 |
EX-99.1 2 athnq12018earningsrelease.htm EXHIBIT 99.1 Exhibit 99.1 athenahealth Reports First Quarter Fiscal Year 2018 Results Company Achieves Double Digit Revenue Growth and Increases Operating Margin; Reaffirms Fiscal Year 2018 Financial Outlook WATERTOWN, MA – April 26, 2018 – athenahealth, Inc. (NASDAQ: ATHN) (“athenahealth” or “we”), a leading provider of network-enabled services for hospital |
|
| April 26, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 athnq12018form8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2018 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of i |
|
| April 26, 2018 |
Exhibit 99.2 First Quarter Fiscal Year 2018 Prepared Remarks and Supplemental Metrics April 26, 2018 Jonathan Bush, Chief Executive Officer Marc Levine, Chief Financial Officer About These Remarks The following commentary is provided by management in conjunction with the first quarter fiscal year 2018 earnings press release issued by athenahealth, Inc. (“athenahealth” or “we”). These remarks repre |
|
| April 26, 2018 |
ATHN / athenahealth, Inc. 10-Q (Quarterly Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 00 |
|
| April 23, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2018 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission File |
|
| April 5, 2018 |
EXECUTION VERSION FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT This FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT, dated as of March 30, 2018 (this “Amendment”), modifies that certain Amended and Restated Credit Agreement, dated as of May 5, 2015 (as amended, restated, amended and restated, extended, supplemented or otherwise modified in writing from time to time, the “Credit Agreement”), among ATHENAHEALTH, INC. |
|
| April 5, 2018 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2018 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission File |
|
| February 15, 2018 |
Regulation FD Disclosure, Financial Statements and Exhibits Document SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 14, 2018 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| February 15, 2018 |
a2018investorsummitfinal 2018 Investor Summit February 15, 2018 Welcome to our Investor Summit Dana Quattrochi Investor Relations athenahealth? 3 agenda Opening and Closing Remarks Jonathan Bush ? Chief Executive Officer Financial Expectations Marc Levine ? Chief Financial Officer Technology and Platform Strategy Prakash Khot ? Chief Technology Officer Core Services Strategy Kyle Armbrester ? Chie |
|
| February 15, 2018 |
athenahealth Provides Guidance for Fiscal Year 2018 at its Investor Summit Exhibit Exhibit 99.1 athenahealth Provides Guidance for Fiscal Year 2018 at its Investor Summit WATERTOWN, MA - February 14, 2018 - athenahealth, Inc. (NASDAQ: ATHN) (?athenahealth? or ?we?), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, will host its 2018 Investor Summit tomorrow, Thursday, February 15, 2018, at 8:30 a.m. Eastern Time. We will prov |
|
| February 15, 2018 |
Investor presentation, February 15, 2018, furnished herewith. 2018 Investor Summit February 15, 2018 Welcome to our Investor Summit Dana Quattrochi Investor Relations athenahealth© 3 agenda Opening and Closing Remarks Jonathan Bush • Chief Executive Officer Financial Expectations Marc Levine • Chief Financial Officer Technology and Platform Strategy Prakash Khot • Chief Technology Officer Core Services Strategy Kyle Armbrester • Chief Product Officer Network |
|
| February 14, 2018 |
ATHN / athenahealth, Inc. / NOMURA HOLDINGS INC - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 athenahealth, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 04685W103 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which t |
|
| February 12, 2018 |
ATHN / athenahealth, Inc. / VANGUARD GROUP INC Passive Investment athenahealthinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5 )* Name of issuer: athenahealth Inc Title of Class of Securities: Common Stock CUSIP Number: 04685W103 Date of Event Which Requires Filing of this Statement: December 31, 2017 Check the appropriate box to |
|
| February 9, 2018 |
Exhibit 24.1 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the person whose signature appears below hereby constitutes and appoints Dan Haley, Jessica Collins, Ben Landry, and Sarah Papagelis, and any one of them acting singly, the true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for the undersigned and in the undersigned's name, place, and |
|
| February 8, 2018 |
ATHN / athenahealth, Inc. / Wellington Management Group LLP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4 )* athenahealth, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 04685W103 (CUSIP Number) December 29, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch |
|
| February 7, 2018 |
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2018 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commi |
|
| February 7, 2018 |
Exhibit Exhibit 99.1 Jeff Immelt Appointed Chairman of athenahealth Board of Directors Brings Deep Industry Knowledge and Relationships in Healthcare; Adds Digital Expertise to Advance Company’s Platform and Profitable Growth Strategies WATERTOWN, MA – February 7, 2018 – athenahealth, Inc. (NASDAQ: ATHN), a leading provider of network-enabled services for hospital and ambulatory clients nationwide |
|
| February 2, 2018 |
ATHN / athenahealth, Inc. / VANGUARD SPECIALIZED FUNDS Passive Investment athenahealthinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.:1 )* Name of issuer: athenahealth Inc Title of Class of Securities: Common Stock CUSIP Number: 04685W103 Date of Event Which Requires Filing of this Statement: December 31, 2017 Check the appropriate box to d |
|
| February 1, 2018 |
athenahealth Reports Fourth Quarter and Full Year 2017 Results Exhibit Exhibit 99.1 athenahealth Reports Fourth Quarter and Full Year 2017 Results Q4 2017 Financial Results ? 14% Revenue Growth Over Fourth Quarter of 2016 ? GAAP Operating Income of $38.7 million ? Non-GAAP Adjusted Operating Income of $77.6 million ? GAAP Net Income of $31.6 million , or $0.78 Per Diluted Share ? Non-GAAP Adjusted Net Income of $45.1 million , or $1.11 Per Diluted Share Full |
|
| February 1, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 athn-20171231x8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 1, 2018 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of |
|
| February 1, 2018 |
EX-99.2 3 athnq42017preparedremarks.htm EXHIBIT 99.2 Exhibit 99.2 Fourth Quarter and Fiscal Year 2017 Prepared Remarks February 1, 2018 Jonathan Bush, Chief Executive Officer Marc Levine, Chief Financial Officer About These Remarks The following commentary is provided by management in conjunction with the fourth quarter and full year 2017 earnings press release issued by athenahealth, Inc. (“athen |
|
| February 1, 2018 |
Exhibit 10.31 ADDENDUM TO JULY 21, 2017 EMPLOYMENT AGREEMENT This Addendum to the July 21, 2017 Employment Agreement is entered into by and between the athenahealth, Inc. (“Athena”) and John A. Kane. (“Employee”). NOW THEREFORE, in consideration of mutual promises and covenants, Athena and Employee agree as follows: The July 21, 2017 Employment Agreement (“Agreement”) between Athena and Employee s |
|
| February 1, 2018 |
Subsidiaries of the Registrant EX-21.1 3 athn-20171231xex211.htm EXHIBIT 21.1 Exhibit 21.1 Subsidiaries of Registrant Name Jurisdiction of Organization Athena Arsenal, LLC Massachusetts Athena Point Lookout, LLC Maine athenahealth MA, Inc. Massachusetts athenahealth Technology Private Limited India Dionysus, LLC Massachusetts Epocrates, LLC Delaware Filament Labs, Inc. Delaware MDP Accelerator, LLC Delaware Praxify Technologies |
|
| February 1, 2018 |
ATHN / athenahealth, Inc. 10-K (Annual Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-336 |
|
| January 4, 2018 |
POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the person whose signature appears below hereby constitutes and appoints Dan Haley, Jessica Collins, Ben Landry, Sarah Papagelis, and Laurie Cerveny, of Morgan, Lewis & Bockius LLP, and any one of them acting singly, the true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for the undersigned and in |
|
| November 27, 2017 |
Employment Agreement by and between the Registrant and Marc A. Levine, dated November 24, 2017 Exhibit EMPLOYMENT AGREEMENT This Employment Agreement (this ? Agreement ?) is entered into as of the date of Employee?s execution hereof, and is effective as of the Effective Date set forth on Schedule A hereto, by and between athenahealth, Inc. |
|
| November 27, 2017 |
8-K 1 form8-kmaldraftvf.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 24, 2017 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction |
|
| November 27, 2017 |
EX-99.1 3 cforeleasevf.htm EXHIBIT 99.1 athenahealth Appoints Marc Levine as Chief Financial Officer and Treasurer Former JDA Software Group, Inc. CFO to Support Company’s Ongoing Profitable Growth and Operational Transformation Plan WATERTOWN, MA – November 27, 2017 – athenahealth, Inc. (NASDAQ: ATHN) a leading provider of network-enabled services for hospital and ambulatory clients nationwide, t |
|
| October 27, 2017 |
8-K 1 athenaform8-kseverancepla.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 23, 2017 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisd |
|
| October 27, 2017 |
athenahealth, Inc. Severance Plan for U.S. Officers and Executives, effective October 23, 2017. exhibit102severanceplanf Exhibit 10.2 ATHENAHEALTH, INC. SEVERANCE PLAN FOR U.S. OFFICERS AND EXECUTIVES Effective October 23, 2017 TABLE OF CONTENTS Page -i- ARTICLE I PURPOSE, INTENT AND TERM OF PLAN .................................... 1 Section 1.01 Purpose and Intent of the Plan ....................................................... 1 Section 1.02 Term of the Plan............................ |
|
| October 27, 2017 |
exhibit101changeinctrlse Exhibit 10.1 ATHENAHEALTH, INC. CHANGE IN CONTROL SEVERANCE PLAN FOR CERTAIN U.S. OFFICERS AND EXECUTIVES Effective October 23, 2017 TABLE OF CONTENTS Page i ARTICLE I BACKGROUND, PURPOSE AND TERM OF PLAN .................................. 1 Section 1.01 Purpose of the Plan ........................................................................ 1 Section 1.02 Term of the |
|
| October 19, 2017 |
8-K 1 athnq32017form8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 13, 2017 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of |
|
| October 19, 2017 |
EX-99.1 3 athnq32017earningsrelease.htm EXHIBIT 99.1 Exhibit 99.1 athenahealth Reports Third Quarter Fiscal Year 2017 Results Revises Fiscal Year 2017 Financial Outlook Provides Update on Strategic Initiatives to Drive Increased Levels of Profitable Growth and Enhance Shareholder Value Increases Targeted Cost Savings of $100 Million to $115 Million in Expense Savings Reiterates Commitment to Signi |
|
| October 19, 2017 |
EX-10.1 2 ex101-october2017addendumt.htm EXHIBIT 10.1 Exhibit 10.1 ADDENDUM TO FEBRUARY 18, 2011 EMPLOYMENT AGREEMENT This Addendum to the February 18, 2011 Employment Agreement is entered into by and between the athenahealth, Inc. (“Athena”) and Stephen N. Kahane, M.D. (“Employee”). NOW THEREFORE, in consideration of mutual promises and covenants, Athena and Employee agree as follows: The Februar |
|
| October 19, 2017 |
EX-99.2 4 athnq32017preparedremarks.htm EXHIBIT 99.2 Exhibit 99.2 Third Quarter Fiscal Year 2017 Prepared Remarks October 19, 2017 Jonathan Bush, Chief Executive Officer Jack Kane, Director and interim Chief Financial Officer About These Remarks The following commentary is provided by management in conjunction with the third quarter fiscal year 2017 earnings press release issued by athenahealth, I |
|
| October 19, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| September 6, 2017 |
POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the person whose signature appears below hereby constitutes and appoints Dan Haley, Jessica Collins, Lan Marinelli, Sarah Papagelis, and Laurie Cerveny, of Morgan Lewis, and any one of them acting singly, the true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for the undersigned and in the undersi |
|
| September 5, 2017 |
Brian McKeon Joins athenahealth Board of Directors EX-99.1 2 athnpressreleaseboardmemb.htm EXHIBIT 99.1 Exhibit 99.1 Brian McKeon Joins athenahealth Board of Directors WATERTOWN, Mass. – September 5, 2017 – athenahealth, Inc. (NASDAQ: ATHN) a leading provider of network-enabled services for hospitals and physician groups, today announced the appointment of Brian McKeon, current IDEXX Laboratories, Inc. (NASDAQ: IDXX) chief financial officer, to it |
|
| September 5, 2017 |
athenahealth FORM 8-K (Current Report/Significant Event) Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 1, 2017 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Comm |
|
| August 10, 2017 |
Exhibit Exhibit 10.1 EXHIBIT A TO THE SUPPORT AGREEMENT BETWEEN ATHENA AND AHS INDIA AMENDED AND RESTATED SERVICES AGREEMENT This Amended and Restated Services Agreement (this ? Agreement ?) is entered into as of August 8, 2017 (the ? Amendment Effective Date ?), by and between athenahealth, Inc., a Delaware corporation with a primary business address of 311 Arsenal Street, Watertown, Massachusett |
|
| August 10, 2017 |
athenahealth 8-K (Current Report/Significant Event) Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2017 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commiss |
|
| August 1, 2017 |
Exhibit Exhibit 99.1 athenahealth Announces Strategic Initiatives to Drive Increased Levels of Profitable Growth and Enhance Shareholder Value Targeting Approximately $100 Million in Cost-Savings to Increase Profitability and Drive Growth Committing to Significant Operating Margin Expansion Launching Search to Recruit Seasoned Independent Chairman of the Board and Additional Independent Director A |
|
| August 1, 2017 |
athenahealth 8-K (Current Report/Significant Event) Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2017 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commiss |
|
| July 25, 2017 |
athenahealth 8-K/A (Current Report/Significant Event) Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 10, 2017 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of inco |
|
| July 25, 2017 |
Exhibit Exhibit 10.2 EMPLOYMENT AGREEMENT This Employment Agreement (this ? Agreement? ) is effective as of July 21, 2017 (the ? Effective Date ?), by and between athenahealth, Inc. (? Athena ?) and John A. Kane (? Employee ?). WHEREAS, Employee serves as a member of Athena?s Board of Directors; WHEREAS, Athena wishes to employ Employee to serve as its chief financial officer on an interim basis w |
|
| July 20, 2017 |
EX-99.1 2 athnq22017earningsrelease.htm EXHIBIT 99.1 Exhibit 99.1 athenahealth, Inc. Reports Second Quarter Fiscal Year 2017 Results Company Achieves 15% Revenue Growth and Expands Operating Margin; Reaffirms Fiscal Year 2017 Financial Outlook Q2 2017 Financial Results • 15% Revenue Growth Over Second Quarter of 2016 • GAAP Operating Income of $12.2 million • Non-GAAP Adjusted Operating Income of |
|
| July 20, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 20, 2017 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission File N |
|
| July 20, 2017 |
EX-99.2 3 athnq22017preparedremarks.htm EXHIBIT 99.2 Exhibit 99.2 Second Quarter Fiscal Year 2017 Prepared Remarks July 20, 2017 Jonathan Bush, Chief Executive Officer Karl Stubelis, outgoing Chief Financial Officer Jack Kane, Director and interim Chief Financial Officer About These Remarks The following commentary is provided by management in conjunction with the second quarter fiscal year 2017 e |
|
| July 20, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001 |
|
| July 14, 2017 |
Exhibit Exhibit 10.1 Daniel Haley Senior Vice President and General Counsel athenahealth, Inc. 311 Arsenal Street Watertown, MA 02472 [email protected] July 10, 2017 BY EMAIL ([email protected]) Karl Stubelis [address omitted] Dear Karl: The purpose of this letter agreement (this ? Agreement ?) is to confirm the terms of the remainder of your employment with athenahealth, Inc. (the |
|
| July 14, 2017 |
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 10, 2017 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commissi |
|
| July 14, 2017 |
EX-99.1 3 exhibit991.htm EXHIBIT 99.1 Exhibit 99.1 athenahealth Announces Chief Financial Officer Transition John A. Kane Appointed Interim Chief Financial Officer Karl Stubelis Steps Down to Pursue Other Opportunities Company Reaffirms Fiscal Year 2017 Guidance WATERTOWN, Mass. – July 14, 2017 – athenahealth, Inc. (NASDAQ: ATHN), a leading provider of network-enabled services for hospital and amb |
|
| June 23, 2017 |
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 23, 2017 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commissio |
|
| June 8, 2017 |
Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 7, 2017 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission |
|
| June 8, 2017 |
Exhibit Exhibit 99.1 athenahealth Agrees to Acquire Praxify Technologies to Advance Cloud Platform and Mobile Innovation Companies Partner to Reduce Inefficiencies and Drive Intelligence at the Point of Care WATERTOWN, Mass. ? June 8, 2017? athenahealth, Inc. (NASDAQ: ATHN), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, today announced that it has e |
|
| May 18, 2017 |
ATHN / athenahealth, Inc. / Elliott Associates, L.P. - MAY 18, 2017 Activist Investment SC 13D 1 athena13d-051817.htm MAY 18, 2017 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (RULE 13D - 101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(a) (Amendment No. )* athenahealth, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 04685W103 (CUSIP Number) Christopher |
|
| May 10, 2017 |
SC 13G 1 athn13gapr17.htm ATHN AS OF 04/30/2017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) ATHENAHEALTH INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 04685W103 (CUSIP Number) April 30, 2017 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate |
|
| April 27, 2017 |
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule |
|
| April 27, 2017 |
Document Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 27, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 27, 2017 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commissi |
|
| April 27, 2017 |
Exhibit First Quarter Fiscal Year 2017 Prepared Remarks April 27, 2017 Jonathan Bush, Chairman & Chief Executive Officer Karl Stubelis, Senior Vice President, Chief Financial Officer About These Remarks The following commentary is provided by management in conjunction with the first quarter fiscal year 2017 earnings press release issued by athenahealth, Inc. |
|
| April 27, 2017 |
EX-99.1 2 athnq12017earningsrelease.htm EXHIBIT 99.1 athenahealth, Inc. Reports First Quarter Fiscal Year 2017 Results Company Revises Fiscal Year 2017 Financial Outlook Q1 2017 Financial Results • 11% Revenue Growth Over First Quarter of 2016 • GAAP Operating Income of $1.1 million • Non-GAAP Adjusted Operating Income of $22.0 million • GAAP Net Loss of $1.4 million, or loss of $0.03 Per Diluted |
|
| April 27, 2017 |
DIRECTOR COMPENSATION PLAN (Effective February 7, 2017) The Director Compensation Plan (the “Plan”) of athenahealth, Inc. |
|
| April 27, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 00 |
|
| April 26, 2017 |
athenahealth 10-K/A (Annual Report) Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Num |
|
| April 26, 2017 |
Exhibit EXHIBIT 10.25 SERVICES AGREEMENT This Services Agreement (this ?Agreement?) is entered into as of July 31, 2013 (the ?Effective Date?), by and between athenahealth, Inc., a Delaware corporation with a primary business address of 311 Arsenal Street, Watertown, Massachusetts 02472 USA (hereinafter referred to as ?Athena?), and Access Healthcare Services USA, LLC, a Delaware limited liability |
|
| March 24, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 22, 2017 athenahealth, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission File |
|
| March 24, 2017 |
Exhibit Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF ATHENAHEALTH, INC. (A Delaware Corporation) As adopted on and with effect from March 22, 2017 AMENDED AND RESTATED BYLAWS OF ATHENAHEALTH, INC. (A Delaware Corporation) As adopted on and with effect from March 22, 2017 ARTICLE I SECTION 1. Annual Meeting . The annual meeting of stockholders (any such meeting being referred to in these Bylaws as an |
|
| February 13, 2017 |
ATHN / athenahealth, Inc. / VANGUARD SPECIALIZED FUNDS Passive Investment athenahealthinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.:0 )* Name of issuer: athenahealth Inc Title of Class of Securities: Common Stock CUSIP Number: 04685W103 Date of Event Which Requires Filing of this Statement: December 31, 2016 Check the appropriate box to d |
|
| February 9, 2017 |
ATHN / athenahealth, Inc. / VANGUARD GROUP INC Passive Investment athenahealthinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4 )* Name of issuer: athenahealth Inc Title of Class of Securities: Common Stock CUSIP Number: 04685W103 Date of Event Which Requires Filing of this Statement: December 31, 2016 Check the appropriate box to |
|
| February 9, 2017 |
athenahealth SEC SCHEDULE 13G (Passive Acquisition of More Than 5% of Shares) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* athenahealth, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 04685W103 (CUSIP Number) December 30, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch |
|
| February 2, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 2, 2017 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commis |
|
| February 2, 2017 |
Exhibit athenahealth, Inc. Reports Fourth Quarter and Full Year 2016 Results Company Announces Fiscal Year 2016 Bookings of $348 Million and Reaffirms Fiscal Year 2017 Guidance Q4 2016 Financial Results ? 12% Revenue Growth Over Fourth Quarter of 2015 ? GAAP Operating Income of $12.4 million ? Non-GAAP Adjusted Operating Income of $42.5 million ? GAAP Net Income of $9.8 million , or $0.24 Per Dilu |
|
| February 2, 2017 |
EX-99.2 3 athnq42016preparedremarks.htm EXHIBIT 99.2 Fourth Quarter and Fiscal Year 2016 Prepared Remarks February 2, 2017 Jonathan Bush, Chairman & Chief Executive Officer Karl Stubelis, Senior Vice President, Chief Financial Officer About These Remarks The following commentary is provided by management in conjunction with the fourth quarter and full year 2016 earnings press release issued by ath |
|
| February 2, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K 10-K 1 athn-20161231x10k.htm 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from |
|
| February 2, 2017 |
SERVICES AGREEMENT This Services Agreement (this ?Agreement?) is entered into as of July 31, 2013 (the ?Effective Date?), by and between athenahealth, Inc. |
|
| February 2, 2017 |
Document A102TM – 2007 Standard Form of Agreement Between Owner and Contractor where the basis of payment is the Cost of the Work Plus a Fee with a Guaranteed Maximum Price AGREEMENT made as of the day of December, 2016 BETWEEN the Owner: Athena Arsenal, LLC 311 Arsenal Street Watertown, MA 02472 Telephone Number: (617) 402-1898 and the Contractor: C. |
|
| February 2, 2017 |
ATHENAHEALTH, INC. DIRECTOR COMPENSATION PLAN (Effective January 1, 2017) ATHENAHEALTH, INC. DIRECTOR COMPENSATION PLAN (Effective January 1, 2017) The Director Compensation Plan (the “Plan”) of athenahealth, Inc. (the “Company”) applies to non-employee directors (each, a “Director”), who shall receive the compensation set forth in this Plan for their service on the Company’s Board of Directors (the “Board”). Cash Compensation* Annual Cash Retainers Amount Director $60, |
|
| February 2, 2017 |
EXHIBIT 21.1 Subsidiaries of Registrant Name Jurisdiction of Organization Athena Arsenal, LLC Massachusetts Athena Point Lookout, LLC Maine athenahealth MA, Inc. Massachusetts athenahealth Technology Private Limited India Dionysus, LLC Massachusetts Epocrates, LLC Delaware Filament Labs, Inc. Delaware MDP Accelerator, LLC Delaware Razor Insights, LLC Georgia RazorInsights Technology Private Limite |
|
| December 15, 2016 |
19th Annual Investor Summit December 15, 2016 2Welcome to our 9th Annual Investor Summit Dana Quattrochi Investor Relations Agenda Opening & Closing Remarks Jonathan Bush, Chairman & Chief Executive Officer1 2 Business Model and Financial GuidanceKarl Stubelis, Chief Financial Officer 4 The Network: Going Deep and Expanding across the ContinuumKyle Armbrester, Chief Product Officer 5 The Network is the Growth Engine for the FutureJonathan Porter, Network Services 6 The Network is the PlatformPrakash Khot, Chief Technology Officer 7 Client Panel DiscussionStephen Kahane, M. |
|
| December 15, 2016 |
EX-99.2 3 exhibit992investorsummit.htm EXHIBIT 99.2 1 9th Annual Investor Summit December 15, 2016 2 Welcome to our 9th Annual Investor Summit Dana Quattrochi Investor Relations Agenda Opening & Closing Remarks Jonathan Bush, Chairman & Chief Executive Officer1 2 Business Model and Financial GuidanceKarl Stubelis, Chief Financial Officer 4 The Network: Going Deep and Expanding across the Continuum |
|
| December 15, 2016 |
Regulation FD Disclosure, Financial Statements and Exhibits Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 14, 2016 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commi |
|
| December 15, 2016 |
Exhibit athenahealth, Inc. Reaffirms Fiscal Year 2016 Guidance and Initiates Guidance for Fiscal Year 2017 Fiscal Year 2017 Guidance Points to Continued Strong Revenue Growth and Improved Profitability WATERTOWN, MA - December 14, 2016 - athenahealth, Inc. (NASDAQ: ATHN) (?athenahealth? or ?we?), a leading provider of network-enabled services and mobile applications for healthcare providers nation |
|
| December 8, 2016 |
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 5, 2016 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commis |
|
| December 8, 2016 |
Ed Park Appointed to athenahealth, Inc. Board of Directors, Effective January 1, 2017 Exhibit Ed Park Appointed to athenahealth, Inc. Board of Directors, Effective January 1, 2017 WATERTOWN, Mass.? Dec. 8, 2016 ? athenahealth, Inc. (NASDAQ: ATHN), a leading provider of network-enabled services and mobile applications for healthcare providers nationwide, today announced Ed Park, its executive vice president and chief operating officer, has been appointed to the company?s board of di |
|
| October 20, 2016 |
Exhibit athenahealth, Inc. Reports Third Quarter Fiscal Year 2016 Results Company Announces Record Provider Additions; Management Reaffirms Fiscal Year 2016 Guidance Q3 2016 Financial Results ? 17% Revenue Growth Over Third Quarter of 2015 ? GAAP Operating Income of $15.2 million ? Non-GAAP Adjusted Operating Income of $41.5 million ? GAAP Net Income of $13.9 million , or $0.35 Per Diluted Share ? |
|
| October 20, 2016 |
athenahealth 8-K (Current Report/Significant Event) Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 20, 2016 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commis |
|
| October 20, 2016 |
EX-99.2 3 athnq32016preparedremarks.htm EXHIBIT 99.2 Third Quarter Fiscal Year 2016 Prepared Remarks October 20, 2016 Jonathan Bush, Chairman & Chief Executive Officer Karl Stubelis, Senior Vice President, Chief Financial Officer About These Remarks The following commentary is provided by management in conjunction with the third quarter fiscal year 2016 earnings press release issued by athenahealt |
|
| October 20, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Document Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| July 22, 2016 |
Exhibit Second Quarter Fiscal Year 2016 Prepared Remarks July 21, 2016 Jonathan Bush, Chairman & Chief Executive Officer Karl Stubelis, Senior Vice President, Chief Financial Officer About These Remarks The following commentary is provided by management in conjunction with the second quarter fiscal year 2016 earnings press release issued by athenahealth, Inc. |
|
| July 22, 2016 |
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 19, 2016 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incor |
|
| July 22, 2016 |
Exhibit athenahealth, Inc. Reports Second Quarter Fiscal Year 2016 Results Company Reaffirms Fiscal Year 2016 Guidance; Management Points to At or Above Mid-Point of Guidance on Key Performance Metrics Q2 2016 Financial Results ? 17% Revenue Growth Over Second Quarter of 2015 ? GAAP Operating Loss of $1.3 million ? Non-GAAP Adjusted Operating Income of $24.1 million ? GAAP Net Loss of $1.9 million |
|
| July 21, 2016 |
Exhibit Second Quarter Fiscal Year 2016 Prepared Remarks July 21, 2016 Jonathan Bush, Chairman & Chief Executive Officer Karl Stubelis, Senior Vice President, Chief Financial Officer About These Remarks The following commentary is provided by management in conjunction with the second quarter fiscal year 2016 earnings press release issued by athenahealth, Inc. |
|
| July 21, 2016 |
EX-99.1 2 athnq22016earningsrelease.htm EXHIBIT 99.1 athenahealth, Inc. Reports Second Quarter Fiscal Year 2016 Results Company Reaffirms Fiscal Year 2016 Guidance; Management Points to At or Above Mid-Point of Guidance on Key Performance Metrics Q2 2016 Financial Results • 17% Revenue Growth Over Second Quarter of 2015 • GAAP Operating Loss of $1.3 million • Non-GAAP Adjusted Operating Income of |
|
| July 21, 2016 |
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 19, 2016 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commissio |
|
| July 21, 2016 |
Exhibit 10.2 athenahealth, Inc. Dan Haley SVP, General Counsel athenahealth, Inc. 311 Arsenal Street Watertown, MA 02472 [email protected] May 31, 2016 BY EMAIL Kristi Matus Boston, MA 02116 Dear Kristi: As we have discussed, your employment with athenahealth, Inc. (the “Company”) will terminate, effective as of May 31, 2016 (the “Separation Date”). The purpose of this letter (the “Agreement |
|
| July 21, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001 |
|
| June 17, 2016 |
powerofattorneythomasszk POWER OF A TIORNEY KNOW ALL MEN BY TIIESE PRESENTS, that the person whose signature appears below hereby constitutes and appoints Dan Haley, Lan Marinelli, Sarah Papagelis, and Laurie Cerveny, of Morgan, Lewis & Beckius LLP, and any one of them acting singly, the true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for the under |
|
| June 15, 2016 |
athenahealth 8-K (Current Report/Significant Event) Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 14, 2016 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commissio |
|
| June 15, 2016 |
Exhibit Exhibit 99.1 athenahealth Appoints Tom Szkutak to its Board of Directors Former Amazon.com CFO to Lend Experience and Leadership as athenahealth Grows, Scales, and Approaches New Business Opportunities WATERTOWN, Mass. ? June 15, 2016 ? athenahealth, Inc. (NASDAQ: ATHN), a leading provider of network-enabled services and mobile applications for healthcare providers nationwide, today announ |
|
| June 10, 2016 |
athenahealth SEC SCHEDULE 13G (Passive Acquisition of More Than 5% of Shares) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* athenahealth, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 04685W103 (CUSIP Number) May 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule |
|
| May 19, 2016 |
SEC Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 13, 2016 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commis |
|
| May 19, 2016 |
SEC Exhibit Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (this ?Agreement?) is entered into as of the date of the parties? execution hereof and is effective as of the Effective Date set forth on Schedule A hereto, by and between athenahealth, Inc. (?Athena?) and the undersigned Employee (?Employee?). In consideration of the offer of continued employment, Employee?s promotion to a ne |
|
| May 19, 2016 |
SEC Exhibit Exhibit 99.1 athenahealth Appoints New CFO Company Separates Chief Financial and Administrative Role; CFAO Kristi Matus Steps Down WATERTOWN, Mass. – May 19, 2016 – athenahealth, Inc. (NASDAQ: ATHN), a leading provider of network-enabled services and mobile applications for health care providers nationwide, today announced changes to its leadership team. The company will conduct a conf |
|
| May 6, 2016 |
Termination of a Material Definitive Agreement 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 29, 2016 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission |
|
| May 5, 2016 |
8-K |
|
| April 28, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule |
|
| April 28, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 00 |
|
| April 28, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 athnq12016form8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 28, 2016 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of in |
|
| April 28, 2016 |
DEF 14A 1 a2016proxystatement.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, f |
|
| April 28, 2016 |
Exhibit Exhibit 99.2 First Quarter Fiscal Year 2016 Prepared Remarks April 28, 2016 Jonathan Bush, Chairman & Chief Executive Officer Kristi Matus, Executive Vice President, Chief Financial & Administrative Officer About These Remarks The following commentary is provided by management in conjunction with the first quarter fiscal year 2016 earnings press release issued by athenahealth, Inc. (?athen |
|
| April 28, 2016 |
Exhibit Exhibit 99.1 athenahealth, Inc. Reports First Quarter Fiscal Year 2016 Results Company Delivers 24% Consolidated Revenue Growth and Reaffirms Fiscal Year 2016 Guidance Q1 2016 Financial Results ? 24% Revenue Growth Over First Quarter of 2015 ? GAAP Operating Income of $0.3 million ? Non-GAAP Adjusted Operating Income of $24.2 million ? GAAP Net Loss of $0.8 million , or loss of $0.02 Per D |
|
| February 23, 2016 |
S-8 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 04-3387530 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 311 Arsenal Street, Watertown, Massachusetts 02472 (Address of Pr |
|
| February 18, 2016 |
KNOW ALL MEN BY THESE PRESENTS, that the person whose signature appears below hereby constitutes and appoints Dan Haley, Lan Marinelli, Megan Lowe, and Laurie Cerveny, of Morgan Lewis, and any one of them acting singly, the true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for the undersigned and in the undersigned's name, place, and stead, in any and all capacities (until revoked in writing) to sign any Form ID and any and all instruments, certificates, and documents required to be executed on behalf of the undersigned as an individual or on behalf of the undersigned's holding company or partnership, as the case may be, with respect to athenahealth, Inc. |
|
| February 16, 2016 |
KNOW ALL MEN BY THESE PRESENTS, that the person whose signature appears below hereby constitutes and appoints Dan Haley, Lan Marinelli and Megan Lowe and any one of them acting singly, the true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for the undersigned and in the undersigned's name, place, and stead, in any and all capacities (until revoked in writing) to sign any Form ID and any and all instruments, certificates, and documents required to be executed on behalf of the undersigned as an individual or on behalf of the undersigned's holding company or partnership, as the case may be, with respect to athenahealth, Inc. |
|
| February 12, 2016 |
CSLT / Castlight Health, Inc. / ATHENAHEALTH INC - SC 13G - CASTLIGHT Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Castlight Health, Inc. (Name of Issuer) Class B Common Stock, par value $0.0001 per share (Title of Class of Securities) 14862Q100 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to desig |
|
| February 11, 2016 |
athenahealth SEC SCHEDULE 13G (Passive Acquisition of More Than 5% of Shares) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* athenahealth, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 04685W103 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch |
|
| February 11, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4) ATHENAHEALTH INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 04685W103 (CUSIP Number) December 31, 2015 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is |
|
| February 10, 2016 |
ATHN / athenahealth, Inc. / VANGUARD GROUP INC Passive Investment aetnahealthinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3 )* Name of issuer: athenahealth Inc Title of Class of Securities: Common Stock CUSIP Number: 04685W103 Date of Event Which Requires Filing of this Statement: December 31, 2015 Check the appropriate box to d |
|
| February 4, 2016 |
ATHENAHEALTH, INC. DIRECTOR COMPENSATION PLAN (Effective January 1, 2016) EXHIBIT 10.30 ATHENAHEALTH, INC. DIRECTOR COMPENSATION PLAN (Effective January 1, 2016) The Director Compensation Plan (the ?Plan?) of athenahealth, Inc. (the ?Company?) applies to non-employee directors, who shall receive the compensation set forth in this Plan for service on the Board of Directors (the ?Board?). Cash Compensation The meeting fees and retainers set forth below are payable quarter |
|
| February 4, 2016 |
EX-10.22 3 athn-20151231xex1022.htm AMENDMENT NO. 4 TO OFFICE LEASE AGREEMENT EXHIBIT 10.22 AMENDMENT NO. 4 TO OFFICE LEASE AGREEMENT THIS AMENDMENT N0. 4 TO OFFICE LEASE AGREEMENT (this “Amendment”) is made as of the 27th of July, 2015 by and between JAMESTOWN PCM Master Tenant, L.P., a Delaware limited partnership (“Landlord”) and athenahealth, Inc., a Delaware corporation (“Tenant”). RECITALS: |
|
| February 4, 2016 |
EX-99.2 3 athnq42015preparedremarks.htm EXHIBIT 99.2 Fourth Quarter and Fiscal Year 2015 Prepared Remarks February 4, 2016 Jonathan Bush, Chairman & Chief Executive Officer Kristi Matus, Executive Vice President, Chief Financial & Administrative Officer About These Remarks The following commentary is provided by management in conjunction with the fourth quarter and full year 2015 earnings press re |
|
| February 4, 2016 |
EX-10.21 2 athn-20151231xex1021.htm AMENDMENT NO. 3 TO OFFICE LEASE AGREEMENT EXHIBIT 10.21 AMENDMENT NO. 3 TO OFFICE LEASE AGREEMENT THIS AMENDMENT NO. 3 TO OFFICE LEASE AGREEMENT (this “Amendment”) is made as of the 27th day of February, 2015 by and between JAMESTOWN PCM Master Tenant, L.P., a Delaware limited partnership (“Landlord”) and athenahealth, Inc., a Delaware corporation (“Tenant”). RE |
|
| February 4, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 4, 2016 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission |
|
| February 4, 2016 |
EXHIBIT 21.1 Subsidiaries of Registrant Name Jurisdiction of Organization Athena Arsenal, LLC Massachusetts Athena Point Lookout, LLC Maine athenahealth MA, Inc. Massachusetts athenahealth Technology Private Limited India Dionysus, LLC Massachusetts Epocrates, Inc. Delaware MDP Accelerator, LLC Delaware Modality, Inc. North Carolina Razor Insights, LLC Georgia RazorInsights Technology Private Limi |
|
| February 4, 2016 |
athenahealth, Inc. Reports Fourth Quarter and Full Year 2015 Results Exhibit athenahealth, Inc. Reports Fourth Quarter and Full Year 2015 Results Q4 2015 Financial Results ? 21% Revenue Growth Over Fourth Quarter of 2014 ? Non-GAAP Adjusted Operating Income of $31.3 million ? GAAP Net Income of $7.7 million , or $0.19 Per Diluted Share ? Non-GAAP Adjusted Net Income of $17.8 million , or $0.45 Per Diluted Share Full Year 2015 Financial Results ? 23% Revenue Growth |
|
| February 4, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-336 |
|
| January 8, 2016 |
KNOW ALL MEN BY THESE PRESENTS, that the person whose signature appears below hereby constitutes and appoints Dan Haley, Lan Marinelli and Megan Lowe and any one of them acting singly, the true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for the undersigned and in the undersigned's name, place, and stead, in any and all capacities (until revoked in writing) to sign any Form ID and any and all instruments, certificates, and documents required to be executed on behalf of the undersigned as an individual or on behalf of the undersigned's holding company or partnership, as the case may be, with respect to athenahealth, Inc. |
|
| December 10, 2015 |
a2015investorsummitfinal 8th Annual Investor Summit December 10, 2015 Welcome to Our 8th Annual Investor Summit Dana Quattrochi Investor Relations Agenda 3 Opening Remarks Jonathan Bush, Chairman & Chief Executive Officer 1 2 Business Model and Financial Guidance Kristi Matus, Chief Financial & Administrative Officer 3 Network Hitting a Tipping Point Doran Robinson, athenaCoordinator 4 Network Expanding Across the Continuum Kyle Armbrester, Chief Product Officer 5 Network Fueling Growth Tim O?Brien, Chief Marketing Officer 6 Client Panel Discussion Stephen Kahane, M. |
|
| December 10, 2015 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 10, 2015 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission |
|
| October 22, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| October 22, 2015 |
EX-10.2 3 athn-20150930xex102.htm EMPLOYMENT AGREEMENT BY AND BETWEEN THE REGISTRANT AND DAN HALEY Exhibit 10.2 EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is entered into as of the Effective Date set forth on Schedule A hereto, by and between athenahealth, Inc. (“Athena”) and the undersigned Employee (“Employee”). The parties agree as follows: I. Employment; Term a. Athena h |
|
| October 22, 2015 |
EX-99.2 3 athnq32015preparedremarks.htm PREPARED REMARKS Third Quarter Fiscal Year 2015 Prepared Remarks October 22, 2015 Jonathan Bush, Chairman & Chief Executive Officer Kristi Matus, Executive Vice President, Chief Financial & Administrative Officer About These Remarks The following commentary is provided by management in conjunction with the third quarter fiscal year 2015 earnings press releas |
|
| October 22, 2015 |
Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (this ?Agreement?) is entered into as of the Effective Date set forth on Schedule A hereto, by and between athenahealth, Inc. (?Athena?) and the undersigned Employee (?Employee?). The parties agree as follows: 1. Employment; Term a. Athena hereby employs Employee, and Employee accepts employment with Athena, upon the terms and conditions |
|
| October 22, 2015 |
EX-99.1 2 athnq32015earningsrelease.htm PRESS RELEASE athenahealth, Inc. Reports Third Quarter Fiscal Year 2015 Results Company Announces Record Physician Additions Q3 2015 Financial Results • 24% Revenue Growth Over Third Quarter of 2014 • Non-GAAP Adjusted Operating Income of $25.4 million • GAAP Net Income of $5.8 million, or $0.15 Per Diluted Share • Non-GAAP Adjusted Net Income of $14.3 milli |
|
| October 22, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 22, 2015 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission |
|
| September 25, 2015 |
KNOW ALL MEN BY THESE PRESENTS, that the person whose signature appears below hereby constitutes and appoints Dan Haley, Lan Marinelli and Megan Lowe and any one of them acting singly, the true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for the undersigned and in the undersigned's name, place, and stead, in any and all capacities (until revoked in writing) to sign any Form ID and any and all instruments, certificates, and documents required to be executed on behalf of the undersigned as an individual or on behalf of the undersigned's holding company or partnership, as the case may be, with respect to athenahealth, Inc. |
|
| September 25, 2015 |
KNOW ALL MEN BY THESE PRESENTS, that the person whose signature appears below hereby constitutes and appoints Dan Haley, Lan Marinelli and Megan Lowe and any one of them acting singly, the true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for the undersigned and in the undersigned's name, place, and stead, in any and all capacities (until revoked in writing) to sign any Form ID and any and all instruments, certificates, and documents required to be executed on behalf of the undersigned as an individual or on behalf of the undersigned's holding company or partnership, as the case may be, with respect to athenahealth, Inc. |
|
| September 10, 2015 |
ATHN / athenahealth, Inc. / Wellington Management Group LLP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* athenahealth, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 04685W103 (CUSIP Number) August 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedul |
|
| September 9, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 9, 2015 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commi |
|
| September 9, 2015 |
EX-99.1 Exhibit 99.1 athenahealth Announces New Executive Roles and Responsibilities Tim O?Brien to Become Chief Marketing Officer; Rob Cosinuke to Head Leadership Institute; Dan Haley Named General Counsel; Kyle Armbrester to Hold Chief Product Officer Position WATERTOWN, Mass., September 9, 2015 ? athenahealth, Inc. (ATHN), a leading provider of cloud-based services and mobile applications for m |
|
| July 23, 2015 |
EX-10.1 2 athn-20150630xex10x1.htm AMENDED AND RESTATED CREDIT AGREEMENT EXHIBIT 10.1 Published CUSIP Number: 04685YAF6 AMENDED AND RESTATED CREDIT AGREEMENT Dated as of May 5, 2015 among ATHENAHEALTH, INC., as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and an L/C Issuer, and The Other Lenders Party Hereto MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED, TD |
|
| July 23, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ATHNQ22015Form8k UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 23, 2015 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (C |
|
| July 23, 2015 |
EX-10.2 3 athn-20150630xex10x2.htm FIRST AMENDMENT TO LEASE EXHIBIT 10.2 FIRST AMENDMENT TO LEASE (athenahealth, Inc.) THIS FIRST AMENDMENT TO LEASE (“First Amendment”) is made and entered into as of May 12, 2015 (the “Effective Date”), by and between SEAHOLM L/R, LLC, a Texas limited liability company (“Landlord”), and athenahealth, INC., a Delaware corporation (“Tenant”). RECITALS A. Landlord an |
|
| July 23, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001 |
|
| July 23, 2015 |
ATHNQ22015EarningsRelease athenahealth, Inc. Reports Second Quarter Fiscal Year 2015 Results Company Grows Network to over 67,000 Providers and Signs Two Academic Medical Centers Q2 2015 Financial Results ? 21% Revenue Growth Over Second Quarter of 2014 ? Non-GAAP Adjusted Operating Income of $22.2 million ? GAAP Net Income of $9.3 million , or $0.24 Per Diluted Share ? Non-GAAP Adjusted Net Incom |
|
| July 23, 2015 |
ATHNQ22015PreparedRemarks Second Quarter Fiscal Year 2015 Prepared Remarks July 23, 2015 Jonathan Bush, Chairman & Chief Executive Officer Kristi Matus, Executive Vice President, Chief Financial & Administrative Officer About These Remarks The following commentary is provided by management in conjunction with the second quarter fiscal year 2015 earnings press release issued by athenahealth, Inc. |
|
| June 11, 2015 |
Submission of Matters to a Vote of Security Holders ATHN8K-2015annualmeeting UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 11, 2015 |
athenahealth FORM 8-K (Current Report/Significant Event) form8k2015-05-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 5, 2015 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Com |
|
| April 30, 2015 |
EX-99.2 3 athnq12015preparedremarks.htm PREPARED REMARKS First Quarter Fiscal Year 2015 Prepared Remarks April 30, 2015 Jonathan Bush, Chairman & Chief Executive Officer Kristi Matus, Executive Vice President, Chief Financial & Administrative Officer About These Remarks The following commentary is provided by management in conjunction with the first quarter fiscal year 2015 earnings press release |
|
| April 30, 2015 |
EMPLOYMENT AGREEMENT v7.4 THIS EMPLOYMENT AGREEMENT (“Agreement’) is made and entered into as of July 1, 2010 by and between ATHENAHEALTH, INC. (the “Company”), and the undersigned Employee (“Employee”). The parties hereby agree as follows: 1.Employment; Term. (a) The Company employs Employee, and Employee accepts employment with the Company, upon the terms and conditions contained in this Agreeme |
|
| April 30, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ATHNQ12015Form8k UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 30, 2015 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) ( |
|
| April 30, 2015 |
2015 DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by |
|
| April 30, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q 10-Q 1 athn-20150331x10q.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period |
|
| April 30, 2015 |
2015 Proxy Statement Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 30, 2015 |
AMENDMENT NO. 3 TO OFFICE LEASE AGREEMENT AMENDMENT NO. 3 TO OFFICE LEASE AGREEMENT THIS AMENDMENT NO. 3 TO OFFICE LEASE AGREEMENT (this ?Amendment?) is made as of the 27th day of February, 2015 by and between JAMESTOWN PCM Master Tenant, L.P., a Delaware limited partnership (?Landlord?) and athenahealth, Inc., a Delaware corporation (?Tenant?). RECITALS: JAMESTOWN Ponce City Market, L.P., a Delaware limited partnership (?JPCM?) and Tenan |
|
| April 30, 2015 |
ATHNQ12015EarningsRelease athenahealth, Inc. Reports First Quarter Fiscal Year 2015 Results Company Delivers 27% Consolidated Revenue Growth and Reaffirms Fiscal Year 2015 Guidance Q1 2015 Financial Results ? 27% Revenue Growth Over First Quarter of 2014 ? Non-GAAP Adjusted Operating Income of $16.3 million ? GAAP Net Loss of $8.8 million , or $0.23 Per Diluted Share ? Non-GAAP Adjusted Net Income |
|
| February 13, 2015 |
athenahealth SC 13G (Passive Acquisition of More Than 5% of Shares) CSLT13G2015 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Castlight Health, Inc. (Name of Issuer) Class B Common Stock, par value $0.0001 per share (Title of Class of Securities) 14862Q100 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designat |
|
| February 13, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3) ATHENAHEALTH INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 04685W103 (CUSIP Number) December 31, 2014 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is |
|
| February 10, 2015 |
ATHN / athenahealth, Inc. / VANGUARD GROUP INC Passive Investment athenahealthinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2 )* Name of issuer: athenahealth Inc Title of Class of Securities: Common Stock CUSIP Number: 04685W103 Date of Event Which Requires Filing of this Statement: December 31, 2014 Check the appropriate box to |
|
| February 9, 2015 |
ATHENAHEALTH, INC. DIRECTOR COMPENSATION PLAN (Effective January 1, 2015) EX-10.32 2 athn-20141231xexx1032.htm DIRECTOR COMPENSATION PLAN EXHIBIT 10.32 ATHENAHEALTH, INC. DIRECTOR COMPENSATION PLAN (Effective January 1, 2015) The Director Compensation Plan (the “Plan”) of athenahealth, Inc. (the “Company”) applies to non-employee directors, who shall receive the following compensation for service on the Board of Directors: Cash Compensation Meeting Fees* Meeting Fee In |
|
| February 9, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K 10-K 1 athn-20141231x10k.htm 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from |
|
| February 9, 2015 |
EXHIBIT 21.1 Subsidiaries of Registrant Name Jurisdiction of Organization Athena Arsenal, LLC Massachusetts Athena Point Lookout, LLC Maine athenahealth MA, Inc. Massachusetts athenahealth Technology Private Limited India Dionysus, LLC Massachusetts Epocrates, Inc. Delaware MDP Accelerator, LLC Delaware Modality, Inc. North Carolina Razor Insights, LLC Georgia RazorInsights Technology Private Limi |
|
| February 5, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 athn-201412318k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 5, 2015 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction |
|
| February 5, 2015 |
Fourth Quarter and Fiscal Year 2014 Prepared Remarks February 5, 2015 Jonathan Bush, Chairman & Chief Executive Officer Kristi Matus, Executive Vice President, Chief Financial & Administrative Officer About These Remarks The following commentary is provided by management in conjunction with the fourth quarter and full year 2014 earnings press release issued by athenahealth, Inc. |
|
| February 5, 2015 |
athenahealth, Inc. Reports Fourth Quarter and Full Year 2014 Results EX-99.1 2 athnq42014earningsrelease.htm PRESS RELEASE athenahealth, Inc. Reports Fourth Quarter and Full Year 2014 Results Q4 2014 Financial Results • 24% Revenue Growth Over Fourth Quarter of 2013 • Non-GAAP Adjusted Operating Income of $38.5 million • GAAP Net Income of $8.7 million, or $0.22 Per Diluted Share • Non-GAAP Adjusted Net Income of $22.5 million, or $0.58 Per Diluted Share Full Year |
|
| December 24, 2014 |
EXHIBIT 10.1 FIRST AMENDMENT TO CREDIT AGREEMENT This FIRST AMENDMENT TO CREDIT AGREEMENT, dated as of December 18, 2014 (this “Amendment”), modifies that certain Credit Agreement, dated as of May 10, 2013 (as amended, restated, amended and restated, extended, supplemented or otherwise modified in writing from time to time, the “Credit Agreement”), among ATHENAHEALTH, INC., a Delaware corporation |
|
| December 24, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 18, 2014 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission Fil |
|
| December 11, 2014 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 athn2014-12x11x8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 11, 2014 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction o |
|
| December 11, 2014 |
a2014investorsummitfinal 7th Annual Investor Summit December 11, 2014 Welcome to Our 7th Annual Investor Summit! Dana Quattrochi Executive Director, Investor Relations Agenda 3 Opening Remarks Jonathan Bush, Chairman & Chief Executive Officer 1 2 Financial Discussion Kristi Matus, EVP, Chief Financial & Administrative Officer 3 Core Business Update Ed Park, EVP, Chief Operating Officer 4 Emerging Services Update Jeremy Delinsky, SVP, Chief Technology Officer 5 Client Panel Discussion Stephen Kahane, M. |
|
| December 9, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 5, 2014 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission File |
|
| October 17, 2014 |
EX-10.2 3 athn-20140930xex102.htm AMENDMENT NO. 2 TO OFFICE LEASE AGREEMENT AMENDMENT NO. 2 TO OFFICE LEASE AGREEMENT THIS AMENDMENT NO. 2 TO OFFICE LEASE AGREEMENT (this “Amendment”) is made as of the 18th day of August, 2014 by and between JAMESTOWN Ponce City Market, L.P., a Delaware limited partnership (“Landlord”) and athenahealth, Inc., a Delaware corporation (“Tenant”). RECITALS: Landlord a |
|
| October 17, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q 10-Q 1 athn-20140930x10q.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition pe |
|
| October 17, 2014 |
EX-10.1 2 athn-20140930xex101.htm EMPLOYMENT AGREEMENT BY AND BETWEEN THE REGISTRANT AND KRISTI MATUS EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement’) is entered into as of the Effective Date set forth on Schedule A hereto, by and between athenahealth, Inc. (“Athena”) and the undersigned Employee (“Employee”). The parties agree as follows: 1.Employment; Term a. Athena hereby emplo |
|
| October 16, 2014 |
athenahealth, Inc. Reports Third Quarter Fiscal Year 2014 Results Company Announces Record Physician Additions Q3 2014 Financial Results • 26% Revenue Growth Over Third Quarter of 2013 • Non-GAAP Adjusted Operating Income of $18.5 million • GAAP Net Loss of $1.6 million, or $0.04 Per Diluted Share • Non-GAAP Adjusted Net Income of $10.4 million, or $0.27 Per Diluted Share WATERTOWN, MA – October 1 |
|
| October 16, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 16, 2014 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission File |
|
| October 16, 2014 |
EX-99.2 3 athnq32014preparedremarks.htm PREPARED REMARKS Third Quarter Fiscal Year 2014 Prepared Remarks October 16, 2014 Jonathan Bush, Chairman & Chief Executive Officer Kristi Matus, Executive Vice President, Chief Financial & Administrative Officer About These Remarks The following commentary is provided by management in conjunction with the third quarter fiscal year 2014 earnings press releas |
|
| July 18, 2014 |
EX-10.3 4 athn-20140630xex103.htm AMENDMENT NO. 1 TO OFFICE LEASE AGREEMENT AMENDMENT NO. 1 TO OFFICE LEASE AGREEMENT THIS AMENDMENT NO. 1 TO OFFICE LEASE AGREEMENT (this “Amendment”) is made as of the 23rd day of April, 2014 by and between JAMESTOWN Ponce City Market, L.P., a Delaware limited partnership (“Landlord”) and athenahealth, Inc., a Delaware corporation (“Tenant”). RECITALS: Landlord an |
|
| July 18, 2014 |
EPOCRATES, INC. 2010 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: JULY 15, 2010 AMENDED BY THE BOARD OF DIRECTORS: NOVEMBER 11, 2010 APPROVED BY THE STOCKHOLDERS: NOVEMBER 19, 2010 AMENDED BY THE BOARD OF DIRECTORS: DECEMBER 22, 2010 APPROVED BY THE STOCKHOLDERS: JANUARY 5, 2011 TERMINATION DATE: JULY 14, 2020 1. GENERAL. (a) Successor to and Continuation of Prior Plan. The Plan is int |
|
| July 18, 2014 |
EMPLOYMENT AGREEMENT This Employment Agreement (this ?Agreement?) is entered into as of the Effective Date set forth on Schedule A hereto, by and between athenahealth, Inc. |
|
| July 18, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001 |
|
| July 17, 2014 |
EX-99.1 2 athnq22014earningsrelease.htm PRESS RELEASE athenahealth, Inc. Reports Second Quarter Fiscal Year 2014 Results Company Reaffirms Full Year Fiscal 2014 Guidance Q2 2014 Financial Results • 27% Revenue Growth Over Second Quarter of 2013 • Non-GAAP Adjusted Operating Income of $21.6 million • GAAP Net Loss of $2.2 million, or $0.06 Per Diluted Share • Non-GAAP Adjusted Net Income of $12.2 m |
|
| July 17, 2014 |
EX-99.2 3 athnq22014preparedremarks.htm PREPARED REMARKS Second Quarter Fiscal Year 2014 Prepared Remarks July 17, 2014 Jonathan Bush, Chairman & Chief Executive Officer Karl Stubelis, Vice President, Corporate Controller & Acting Chief Financial Officer About These Remarks The following commentary is provided by management in conjunction with the second quarter fiscal year 2014 earnings press rel |
|
| July 17, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 17, 2014 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 24, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 23, 2014 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 24, 2014 |
athenahealth Names Kristi Matus Executive Vice President and Chief Financial & Administrative Officer Company Introduces Chief Financial & Administrative Officer Role, Expanding Responsibilities of Chief Financial Officer to Encompass Broader Operational Functions WATERTOWN, MA – June 24, 2014 – athenahealth, Inc. |
|
| June 23, 2014 |
VIA EDGAR AND OVERNIGHT COURIER June 23, 2014 Securities and Exchange Commission Division of Corporate Finance 100 F. |
|
| June 12, 2014 |
Submission of Matters to a Vote of Security Holders - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 9, 2014 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission File Num |
|
| May 1, 2014 |
8-K 1 athnform8-k20140501.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 29, 2014 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdicti |
|
| May 1, 2014 |
EXHIBIT 99.1 athenahealth Names Karl Stubelis Acting Chief Financial Officer Current CFO, Tim Adams, Steps Down; Company Announces Formal Search for Next General and Administrative Division Leader WATERTOWN, MA – May 1, 2014 – athenahealth, Inc. (NASDAQ: ATHN), a leading provider of cloud-based services for electronic health record (EHR), practice management, and care coordination, today announced |
|
| April 30, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
